Southampton scientists to investigate ways to prevent life-threatening complications in transplant patients

August 21, 2012
Southampton scientists to investigate ways to prevent life-threatening complications in transplant patients
Activated T-Cells.

Scientists from the University of Southampton have received a grant from the blood cancer charity Leukaemia & Lymphoma Research to explore ways of preventing life-threatening side effects in patients receiving bone marrow transplants.

The team, led by Aymen Al-Shamkhani a Professor of Immunology, has received £270,000 for the three-year project to improve , which often offer a last chance of a cure for patients with many different types of .

When transplanted, helps to replenish a healthy blood supply, repairing damage caused by chemotherapy. Among the blood transplanted are T-cells, white blood cells crucial to the body’s immune system that recognise alien cells and fight infection. In a process called graft-vs-leukaemia (GVL), these new T-cells hunt down any malignant leukaemia cells that have survived chemotherapy.

However, in many cases when the donor and patient are not an exact genetic match, donor T-cells also recognise healthy cells as ‘foreign’. The new immune system fights the patient’s body in a complication called graft-vs-host disease (GVHD). This occurs in around half of all bone marrow transplants and can be life-threatening and cause long-term health problems.

One way to reduce the chances of developing GVHD is to remove T-cells from the donor bone marrow at the time of the transplant and providing them a later transfusion.

However, delaying the introduction of T-cells reduces the vital GVL effect, creating a high risk of the blood cancer relapsing.

Prof Al-Shamkhani’s team will address these problems by investigating ways to stimulate donor T-cells so that they only target the cancerous cells and don’t get worn out, thus making the T-cells more effective at fighting the cancer while reducing the chances of GVHD.

Prof Al-Shamkhani said: “Recent research has provided some indication of ways in which GVHD can be prevented, although often the delayed introduction of the T-cells has led to relapse. By gaining a better understanding of the mechanisms of the disease and the way T-cells fight blood cancer, we hope to be able to design treatments that can deliver the best possible chances of survival.”

Professor Chris Bunce, Research Director at Leukaemia & Lymphoma Research, said: “GVHD in blood cancer transplants is a major side-effect and often leads to serious health problems, even if the original disease had been destroyed. The potential benefits of this project could go beyond blood cancers, as GVHD can occur in many transplants.”

Explore further: Bone marrow and blood stem cell transplant survival rates equal, when donor is unrelated to patient

Related Stories

Bone marrow and blood stem cell transplant survival rates equal, when donor is unrelated to patient

December 12, 2011
Patients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likely to have graft failure but less likely to experience graft-versus-host disease, ...

B cell survival holds key to chronic graft vs. host disease

August 16, 2012
Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their ...

Antibodies from rabbits improve survival and relapse outcomes of leukemia and myelodysplasia

July 6, 2012
Researchers at Virginia Commonwealth University (VCU) Massey Cancer Center's Bone Marrow Transplant Program have demonstrated that the use of antibodies derived from rabbits can improve the survival and relapse outcomes of ...

Biomarker detects graft-versus-host-disease in cancer patients after bone marrow transplant

October 21, 2011
A University of Michigan Health System-led team of researchers has found a biomarker they believe can help rapidly identify one of the most serious complications in patients with leukemia, lymphoma and other blood disorders ...

HIV drug reduces graft-vs.-host disease in bone marrow transplant patients

July 11, 2012
An HIV drug that redirects immune cell traffic significantly reduces the incidence of a dangerous complication that often follows bone marrow transplants for blood cancer patients, according to research from the Perelman ...

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.